Bio-Techne (TECH) Current Assets (2009 - 2026)

Bio-Techne has reported Current Assets for 18 years, with the latest figure at $688.0 million in Q1 2026.

• For the quarter ending Q1 2026, Current Assets rose 9.69% year-over-year to $688.0 million; the trailing twelve-month figure through Mar 2026 stood at $688.0 million (up 9.69% YoY), and the FY2025 full-year result was $608.3 million, down 1.48% from the prior year.
• Current Assets for Q1 2026 stood at $688.0 million, up from $637.4 million in the prior quarter.
• The five-year high for Current Assets was $688.0 million in Q1 2026, with the low at $552.0 million in Q3 2022.
• Average Current Assets over 5 years is $610.1 million, with a median of $609.5 million recorded in 2025.
• Year-over-year, Current Assets rose 18.6% in 2022 and dropped 6.02% in 2025.
• Tracing TECH's Current Assets over 5 years: stood at $565.2 million in 2022, then increased by 4.5% to $590.6 million in 2023, then rose by 7.45% to $634.6 million in 2024, then climbed by 0.44% to $637.4 million in 2025, then advanced by 7.94% to $688.0 million in 2026.
• The last three Current Assets figures came in at $688.0 million (Q1 2026), $637.4 million (Q4 2025), and $609.5 million (Q3 2025), per Business Quant data.

Peer Comparison